Results of surgery and prognostic factors

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatic resection is the treatment of choice for colorectal liver metastases, with 5-year survival rates now approaching 60%. Postoperative morbidity and mortality are constantly decreasing. In particular, 90-day postoperative mortality has been reported in several series to be less than 1%. Several prognostic factors of poor outcome have been recognized but, at present, most of them cannot be used to select patients for resection. Future identification of molecular factors may aid in the prediction of prognosis and help to improve the selection of those patients most likely to benefit from surgery.

Original languageEnglish
Title of host publicationSurgical Treatment of Colorectal Liver Metastases
PublisherSpringer Milan
Pages55-74
Number of pages20
ISBN (Print)9788847018082
DOIs
Publication statusPublished - 2011

Fingerprint

Mortality
Liver
Patient Selection
Survival Rate
Neoplasm Metastasis
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ribero, D. (2011). Results of surgery and prognostic factors. In Surgical Treatment of Colorectal Liver Metastases (pp. 55-74). Springer Milan. https://doi.org/10.1007/978-88-470-1809-9_5

Results of surgery and prognostic factors. / Ribero, Dario.

Surgical Treatment of Colorectal Liver Metastases. Springer Milan, 2011. p. 55-74.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ribero, D 2011, Results of surgery and prognostic factors. in Surgical Treatment of Colorectal Liver Metastases. Springer Milan, pp. 55-74. https://doi.org/10.1007/978-88-470-1809-9_5
Ribero D. Results of surgery and prognostic factors. In Surgical Treatment of Colorectal Liver Metastases. Springer Milan. 2011. p. 55-74 https://doi.org/10.1007/978-88-470-1809-9_5
Ribero, Dario. / Results of surgery and prognostic factors. Surgical Treatment of Colorectal Liver Metastases. Springer Milan, 2011. pp. 55-74
@inbook{9d91b084e97e485d8967c7e842d91a2a,
title = "Results of surgery and prognostic factors",
abstract = "Hepatic resection is the treatment of choice for colorectal liver metastases, with 5-year survival rates now approaching 60{\%}. Postoperative morbidity and mortality are constantly decreasing. In particular, 90-day postoperative mortality has been reported in several series to be less than 1{\%}. Several prognostic factors of poor outcome have been recognized but, at present, most of them cannot be used to select patients for resection. Future identification of molecular factors may aid in the prediction of prognosis and help to improve the selection of those patients most likely to benefit from surgery.",
author = "Dario Ribero",
year = "2011",
doi = "10.1007/978-88-470-1809-9_5",
language = "English",
isbn = "9788847018082",
pages = "55--74",
booktitle = "Surgical Treatment of Colorectal Liver Metastases",
publisher = "Springer Milan",

}

TY - CHAP

T1 - Results of surgery and prognostic factors

AU - Ribero, Dario

PY - 2011

Y1 - 2011

N2 - Hepatic resection is the treatment of choice for colorectal liver metastases, with 5-year survival rates now approaching 60%. Postoperative morbidity and mortality are constantly decreasing. In particular, 90-day postoperative mortality has been reported in several series to be less than 1%. Several prognostic factors of poor outcome have been recognized but, at present, most of them cannot be used to select patients for resection. Future identification of molecular factors may aid in the prediction of prognosis and help to improve the selection of those patients most likely to benefit from surgery.

AB - Hepatic resection is the treatment of choice for colorectal liver metastases, with 5-year survival rates now approaching 60%. Postoperative morbidity and mortality are constantly decreasing. In particular, 90-day postoperative mortality has been reported in several series to be less than 1%. Several prognostic factors of poor outcome have been recognized but, at present, most of them cannot be used to select patients for resection. Future identification of molecular factors may aid in the prediction of prognosis and help to improve the selection of those patients most likely to benefit from surgery.

UR - http://www.scopus.com/inward/record.url?scp=84892023960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892023960&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-1809-9_5

DO - 10.1007/978-88-470-1809-9_5

M3 - Chapter

AN - SCOPUS:84892023960

SN - 9788847018082

SP - 55

EP - 74

BT - Surgical Treatment of Colorectal Liver Metastases

PB - Springer Milan

ER -